IS6130A - Bólgueyðandi meðhöndlun fyrir bólgu tengt smit - Google Patents

Bólgueyðandi meðhöndlun fyrir bólgu tengt smit

Info

Publication number
IS6130A
IS6130A IS6130A IS6130A IS6130A IS 6130 A IS6130 A IS 6130A IS 6130 A IS6130 A IS 6130A IS 6130 A IS6130 A IS 6130A IS 6130 A IS6130 A IS 6130A
Authority
IS
Iceland
Prior art keywords
infection
inflammation associated
inflammatory treatment
progression
inhibiting
Prior art date
Application number
IS6130A
Other languages
English (en)
Inventor
A. Anton Peter
A. Poles Michael
V. Giorgi Janis
E. Elliott Julie
Original Assignee
The Regents Of The University Of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2000/013142 external-priority patent/WO2000069255A1/en
Application filed by The Regents Of The University Of California filed Critical The Regents Of The University Of California
Publication of IS6130A publication Critical patent/IS6130A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2026—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1793—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2086—IL-13 to IL-16
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
IS6130A 1999-05-14 2001-10-26 Bólgueyðandi meðhöndlun fyrir bólgu tengt smit IS6130A (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13409199P 1999-05-14 1999-05-14
US09/569,765 US20030138399A1 (en) 1999-05-14 2000-05-12 Anti-inflammatory therapy for inflammatory mediated infection
PCT/US2000/013142 WO2000069255A1 (en) 1999-05-14 2000-05-12 Anti-inflammatory therapy for inflammatory mediated infection

Publications (1)

Publication Number Publication Date
IS6130A true IS6130A (is) 2001-10-26

Family

ID=26831958

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6130A IS6130A (is) 1999-05-14 2001-10-26 Bólgueyðandi meðhöndlun fyrir bólgu tengt smit

Country Status (2)

Country Link
US (1) US20030138399A1 (is)
IS (1) IS6130A (is)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7090201A (en) * 2000-07-20 2002-02-05 Lauras As Method
EP2361620B1 (en) 2004-02-06 2016-04-06 PHARMATEL (R&D) PTY LIMITED as Trustee for the PHARMATEL (R & D) TRUST Use of aminosalicylates in diarrhoea-predominant irritable bowel syndrome
JP5009152B2 (ja) * 2004-05-28 2012-08-22 サリックス ファーマシューティカルズ， インコーポレイテッド 放射線誘発性腸炎の予防、処置、および回復
WO2006100673A2 (en) * 2005-03-21 2006-09-28 Tel Hashomer Medical Research Infrastructure And Services Ltd. Methods of individually optimizing treatment for an inflammation associated disease
PE20061303A1 (es) * 2005-03-30 2006-12-07 Astion Dev As Composicion farmaceutica que comprende oxaprozina
US7452872B2 (en) 2005-08-24 2008-11-18 Salix Pharmaceuticals, Inc. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
US8921344B2 (en) * 2006-11-03 2014-12-30 Salix Pharmaceuticals, Inc. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
CN102670626A (zh) * 2005-08-24 2012-09-19 萨利克斯药品公司 巴柳氮制剂及其生产和应用
WO2008036285A1 (en) * 2006-09-18 2008-03-27 Energex Systems, Inc. Method of treating viral infections with ultraviolet light
US20110280849A1 (en) * 2010-03-26 2011-11-17 Anthrogenesis Corporation Tumor suppression using human placenta-derived intermediate natural killer cells and immunomodulatory compounds
EP2790506A4 (en) * 2011-12-16 2015-02-11 David Gladstone Inst COMPOSITIONS AND METHODS FOR INHIBITING TRANSCRIPTION OF IMMUNODEFICIENCY VIRUS
WO2015061442A1 (en) * 2013-10-22 2015-04-30 Cadila Healthcare Limited Delayed release pharmaceutical compositions of salsalate
EP3084008B1 (en) 2013-12-17 2018-07-18 Csir A method for identification of anti-hiv human mirna mimics and mirna inhibitors and anti-hiv pharmaceutical compounds

Also Published As

Publication number Publication date
US20030138399A1 (en) 2003-07-24

Similar Documents

Publication Publication Date Title
HN2001000244A (es) Inhibidores de espiropirimidin - 2, 4, 6 - triona metaloproteinasas.
TR200200160T2 (tr) Antiinflamatuar ajanlar olarak imidazoller ve triazoller
MXPA01011606A (es) Terapia anti-inflamatoria para infeccion mediada por inflamacion.
BR9910864A (pt) Compostos anti-inflamatórios para inibição de aderência celular
AR027355A1 (es) Acidos tiazolidincarboxilicos
NO20044054L (no) Administrering av midler for behandling av betennelse
MXPA02007915A (es) Mediador de lipido activado por aspirina.
CY1107465T1 (el) Μελαγατρανη για τη θepαπευτικη αντιμετωπιση φλεγμονων
IS6130A (is) Bólgueyðandi meðhöndlun fyrir bólgu tengt smit
ES2192839T3 (es) Timosina beta 4 oxidada.
NO20030748D0 (no) Prodruger av betulinsyre for behandlingen av kreft og HIV
DK1397105T3 (da) Præparat til inhibering af angiogenese
SE0101932D0 (sv) Pharmaceutical combinations
EE200200471A (et) Farmatseutiline kompositsioon, mis sisaldab kamptotetsiini või selle derivaati kombinatsioonis pürimidiini derivaadiga ning on ette nähtud vähktõve raviks
AU2732597A (en) Novel pharmaceutical compositions having steroid nitrate ester derivatives useful as anti-inflammatory drugs
DK0869965T3 (da) Steroidnitritesterderivater anvendelige som antiinflammatoriske lægemidler
IT1318667B1 (it) Medicamento antinfiammatorio.
NO20026244D0 (no) Neurobeskyttende 7-beta-hydroksysteroider
SE0004101D0 (sv) New use
NO20021573D0 (no) Tverrbundne kopolymerer basert på ikke-tverrbundne polykarboksylkopolymerer
IL153541A0 (en) The use of 7-hydroxyepiandrosterone for the manufacture of pharmaceutical compositions
AR027677A1 (es) Una composicion farmaceutica terapeutica que comprende camptotecina y ciclofosfamida para el tratamiento del cancer
DE60039122D1 (de) 6-o-alkyl-2-nor-2-substituierte ketolidderivate
UA38006A (uk) Хондропротективний препарат
CY1107334T1 (el) Μεθοδοι για την αναστολη της αγγειογενεσης